A randomized, double-blinded, parallel-group study in patients with iron deficiency anemia
Phase 3
Completed
- Conditions
- Iron Deficiency Anemia
- Registration Number
- JPRN-jRCT2080223942
- Lead Sponsor
- JAPAN TABACCO INC.
- Brief Summary
The efficacy and safety of JTT-751 were confirmed in patients with iron deficiency anemia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 518
Inclusion Criteria
Iron deficiency anemia
Hemoglobin level of >= 7.0 g/dL and < 11.0 g/d
Exclusion Criteria
Anemia caused by other than iron deficiency
Serum phosphate < 2.5 mg/dL
Uncontrollable treatment potentially affecting bleeding in patients with bleeding lesion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method